RIL
AMLX icon

Rothschild Investment LLC’s Amylyx Pharmaceuticals AMLX Stock Holding History

Rothschild Investment LLC’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$988 Hold
55
– – ﹤0.01% 3048
2026
Q1 		$765 Buy
+55
New +$774 ﹤0.01% 2977

Other funds holding AMLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Rothschild Investment LLC's AMLX Position: Q2 2026 in Review

Rothschild Investment LLC held its Amylyx Pharmaceuticals (AMLX) position steady in Q2 2026 at 55 shares worth $988. The position accounts for ﹤0.01% of the portfolio, ranked #3048.

Rothschild Investment LLC first reported a position in AMLX in Q1 2026 and has held it in 2 quarters since. 52 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Rothschild Investment LLC held 55 shares of Amylyx Pharmaceuticals worth $988 as of Q2 2026.
  • Rothschild Investment LLC left its Amylyx Pharmaceuticals share count unchanged in Q2 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3048 holding.
  • Rothschild Investment LLC first reported a position in Amylyx Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 52 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.